Orlando firm Sciperio's new tech decreases cost of making blood by nearly 95%
Sciperio CEO Kenneth Church’s daughter being born with only one lung triggered an interest in biology, which led him to explore possibilities for stem cells in cord blood.
In light of a deficit of parts available for transplants, scientists have been experimenting with innovative ways to grow human body parts from stem cells. That need led Church and his team at Orlando-based Sciperio to manufacture blood, and over time they’ve been able to reduce the cost of doing that by nearly 95%, with the goal of cutting the cost even more eventually — enough to compete with the cost of buying donated blood. […]